Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Merck
MRK
|
+$921M |
| 2 |
Union Pacific
UNP
|
+$581M |
| 3 |
Salesforce
CRM
|
+$417M |
| 4 |
Edwards Lifesciences
EW
|
+$409M |
| 5 |
ServiceNow
NOW
|
+$316M |
Top Sells
| 1 |
Caterpillar
CAT
|
+$664M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$632M |
| 3 |
Texas Instruments
TXN
|
+$571M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$540M |
| 5 |
Parker-Hannifin
PH
|
+$513M |
Sector Composition
| 1 | Technology | 21.1% |
| 2 | Healthcare | 17.5% |
| 3 | Consumer Discretionary | 17.06% |
| 4 | Financials | 12.7% |
| 5 | Communication Services | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICD
476
DELISTED
Independence Contract Drilling, Inc.
ICD
| $5.57M | 0.01% |
89,278
+1,346
| +2% | +$84K |
|
|
FSTX
477
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $5.5M | 0.01% |
132,342
-37,991
| -22% | -$1.58M |
|
478
Quanterix
QTRX
$223M
| $5.45M | 0.01% |
297,563
+3,249
| +1% | +$59.5K |
|
|
RDC
479
DELISTED
Rowan Companies Plc
RDC
| $5.33M | 0.01% |
635,317
-122,476
| -16% | -$1.03M |
|
|
IMGN
480
DELISTED
Immunogen Inc
IMGN
| $5.15M | 0.01% |
1,072,821
-100,539
| -9% | -$483K |
|
481
Waste Connections
WCN
$45.8B
| $5.12M | 0.01% |
68,959
-2,088
| -3% | -$155K |
|
|
EQGP
482
DELISTED
EQGP Holdings, LP
EQGP
| $5.08M | 0.01% |
254,453
-11,921
| -4% | -$238K |
|
483
Viking Therapeutics
VKTX
$2.89B
| $4.75M | 0.01% |
620,789
+75,389
| +14% | +$577K |
|
|
IPHI
484
DELISTED
INPHI CORPORATION
IPHI
| $4.53M | 0.01% |
+140,900
| New | +$4.53M |
|
485
Mueller Water Products
MWA
$3.98B
| $4.46M | 0.01% |
490,150
+401,018
| +450% | +$3.65M |
|
486
Select Water Solutions
WTTR
$954M
| $4.37M | ﹤0.01% |
690,620
-47,952
| -6% | -$303K |
|
|
ENLC
487
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $4.16M | ﹤0.01% |
437,940
-20,514
| -4% | -$195K |
|
488
Vanguard Growth ETF
VUG
$189B
| $3.83M | ﹤0.01% |
+28,533
| New | +$3.83M |
|
489
Walt Disney
DIS
$211B
| $3.7M | ﹤0.01% |
33,744
-3,991
| -11% | -$438K |
|
|
AUTL
490
Autolus Therapeutics
AUTL
$381M
| $3.51M | ﹤0.01% |
106,971
-12,219
| -10% | -$401K |
|
491
Antero Midstream
AM
$8.85B
| $3.49M | ﹤0.01% |
312,517
-14,638
| -4% | -$164K |
|
|
DBVT
492
DBV Technologies
DBVT
$272M
| $3.44M | ﹤0.01% |
53,571
-119,558
| -69% | -$7.68M |
|
493
Inspire Medical Systems
INSP
$2.45B
| $3.17M | ﹤0.01% |
75,081
-14,899
| -17% | -$629K |
|
494
RenaissanceRe
RNR
$11.5B
| $3.16M | ﹤0.01% |
23,659
| – | – |
|
495
Fate Therapeutics
FATE
$118M
| $3M | ﹤0.01% |
233,504
-66,496
| -22% | -$853K |
|
496
SPDR S&P MidCap 400 ETF Trust
MDY
$24.2B
| $2.36M | ﹤0.01% |
+7,792
| New | +$2.36M |
|
|
SBT
497
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $2.27M | ﹤0.01% |
326,471
+41,502
| +15% | +$288K |
|
498
Micron Technology
MU
$169B
| $2.14M | ﹤0.01% |
67,277
+32,574
| +94% | +$1.03M |
|
499
SPDR S&P Metals & Mining ETF
XME
$2.4B
| $2.07M | ﹤0.01% |
79,161
-12,477
| -14% | -$327K |
|
500
HCA Healthcare
HCA
$94.3B
| $2.04M | ﹤0.01% |
16,364
-1,838
| -10% | -$229K |
|